News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca PLC (AZN) Digs Deeper in China With Generics Buy



12/8/2011 8:21:57 AM

AstraZeneca is stepping up its drive into emerging markets by buying a Chinese maker of generic injectable antibiotics. The move highlights the growing importance of markets like China for international drugmakers, even as healthcare reforms in the country lead to some slowing in recent rapid growth in demand for medicines. Britain's second biggest drugmaker said on Thursday it was buying privately owned Guangdong BeiKang Pharmaceutical for an undisclosed sum under a deal set to close in the first quarter of 2012.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES